Zai Lab Limited
ZLAB
$18.61
-$0.49-2.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 99.61M | 127.60M | 116.10M | 109.98M | 106.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 99.61M | 127.60M | 116.10M | 109.98M | 106.49M |
| Cost of Revenue | 103.93M | 123.96M | 94.81M | 93.83M | 99.38M |
| Gross Profit | -4.32M | 3.63M | 21.28M | 16.14M | 7.11M |
| SG&A Expenses | 65.07M | 73.04M | 70.11M | 71.04M | 63.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 169.00M | 197.00M | 164.92M | 164.87M | 162.80M |
| Operating Income | -69.39M | -69.41M | -48.82M | -54.90M | -56.31M |
| Income Before Tax | -49.58M | -53.34M | -35.96M | -40.73M | -48.44M |
| Income Tax Expenses | 1.44M | -2.93M | -- | -- | -- |
| Earnings from Continuing Operations | -51.02M | -50.41M | -35.96M | -40.73M | -48.44M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -51.02M | -50.41M | -35.96M | -40.73M | -48.44M |
| EBIT | -69.39M | -69.41M | -48.82M | -54.90M | -56.31M |
| EBITDA | -65.44M | -65.49M | -44.92M | -51.16M | -52.85M |
| EPS Basic | -4.61 | -4.56 | -3.26 | -3.73 | -4.48 |
| Normalized Basic EPS | -0.28 | -0.30 | -0.20 | -0.23 | -0.27 |
| EPS Diluted | -4.61 | -4.56 | -3.26 | -3.73 | -4.48 |
| Normalized Diluted EPS | -0.28 | -0.30 | -0.20 | -0.23 | -0.27 |
| Average Basic Shares Outstanding | 110.74M | 110.61M | 110.21M | 109.19M | 108.08M |
| Average Diluted Shares Outstanding | 11.07M | 11.06M | 11.02M | 10.92M | 10.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |